漏斗形腹腔内补片预防造口旁疝:Chimney随机临床试验
Chimney试验为在芬兰4家医院和瑞典1家医院开展的单盲多中心随机对照研究,纳入143例因直肠腺癌行腹会阴切除术或Hartmann手术的患者。12个月随访CT确认造口旁疝在补片组为6/58(10%),对照组为22/59(37%),差异为27%(95%CI 12-41,P<.001)。
要点
- 漏斗形造口补片可显著降低12个月CT确认的造口旁疝发生率。
- 补片组Clavien-Dindo II级肠梗阻更常见(35%对17%)。
- 其他造口相关并发症、再入院、手术时间及生活质量组间差异不大。
核心结论
- 在12个月随访期内,漏斗形造口补片可显著预防造口旁疝,且未增加补片或造口相关并发症。
- 结果提示漏斗形补片是预防造口旁疝的可行选择。
研究设计与样本
- Chimney试验为随机单盲多中心试验,在芬兰4家医院和瑞典1家医院开展,时间范围2019年2月至2021年9月。
- 439例因直肠腺癌行腹腔镜或机器人辅助腹会阴切除术或Hartmann手术的患者中,143例入组,135例接受分配干预,121例在12个月随访时分析。
主要发现
- 12个月随访时,补片组58例中6例(10%)经CT确认造口旁疝,对照组59例中22例(37%)确认,差异27%(95%CI 12-41,P<.001)。
- 临床造口旁疝为次要结局,补片组60例中1例(2%),对照组61例中27例(43%),差异41%(95%CI 29-55,P<.001)。
- Clavien-Dindo II级肠梗阻补片组23例(35%),对照组11例(17%),差异18%(95%CI 3-32,P=.006)。
关键数值与推荐
- 主要终点为术后12个月CT确认的造口旁疝发生率。
- 补片组68例接受分配干预,平均(SD)年龄68.7(11.6)岁,男性36例(53%),女性32例(47%)。
- 对照组67例接受分配干预,平均(SD)年龄66.4(11.7)岁,男性48例(72%),女性19例(28%)。
临床怎么用
- 对因直肠腺癌行腹会阴切除术或Hartmann手术并需永久性结肠造口的患者,可考虑使用漏斗形腹腔内补片预防造口旁疝。
- 应权衡补片组Clavien-Dindo II级肠梗阻发生率较高的情况。
局限性
- 12个月随访时补片组58例、对照组59例有CT扫描可供分析。
- 其他造口相关并发症、再入院、手术时间、手术部位感染、再手术及生活质量组间仅见轻微差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Prophylactic placement of a mesh has been suggested to prevent parastomal hernia. Evidence to support this practice is contradictory. OBJECTIVE: To determine whether funnel-shaped permanent synthetic parastomal mesh is effective and safe in parastomal hernia prevention. DESIGN, SETTING, AND PARTICIPANTS: The Chimney Trial was a randomized single-blinded multicenter trial conducted in 4 hospitals in Finland and 1 in Sweden from February 2019 and September 2021. Of 439 patients with rectal adenocarcinoma undergoing either laparoscopic or robotic-assisted abdominoperineal resection or the Hartmann procedure, 143 were enrolled in the trial, 135 received their allocated intervention, and 121 were analyzed at 12-month follow-up. Data were analyzed from December 2023 to May 2024. INTERVENTION: In the intervention group, a permanent colostomy was created with a funnel-shaped intraperitoneal mesh and compared to a control group with a stoma without the mesh. MAIN OUTCOME AND MEASURE: The primary end point was the incidence of computed tomography (CT)-confirmed parastomal hernia 12 months after surgery. RESULTS: There were 68 patients (mean [SD] age, 68.7 [11.6] years; 36 [53% male and 32 [47%] female) who received the intended allocation in the mesh group and 67 (mean [SD] age, 66.4 [11.7] years; 48 [72%] male and 19 [28%] female) who received the intended allocation in the control group. CT scans were available for 58 patients in the mesh group and 59 patients in the control group at the 12-month follow-up. CT scans confirmed parastomal hernia in 6 of 58 patients (10%) in the mesh group compared to 22 of 59 patients (37%) in the control group (difference, 27%; 95% CI, 12-41; P < .001). Clinical parastomal hernia as a secondary outcome was recorded in 1 of 60 patients (2%) in the mesh group compared to 27 of 61 (43%) in the control group (difference, 41%; 95% CI, 29-55; P < .001). The number of patients with Clavien-Dindo class II ileus was 23 (35%) in the mesh group compared to 11 (17%) in the control group (difference, 18%; 95% CI, 3-32; P = .006). Only slight differences between the groups were detected in other stoma-related complications, readmissions, operative time, surgical site infections, reoperations, and quality of life. CONCLUSIONS AND RELEVANCE: In this study, funnel-shaped parastomal mesh prevented a significant number of parastomal hernias without predisposing patients to mesh- or stoma-related complications during 12-month follow-up. The results of this study suggest the funnel-shaped mesh is a feasible option to prevent parastomal hernia. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03799939.
引用
- Mäkäräinen E, Wiik H, Nikberg M, et al. Parastomal Hernia Prevention Using Funnel-Shaped Intra-Abdominal Mesh Compared to No Mesh: The Chimney Randomized Clinical Trial. JAMA Surg. 2024. PMID: 39196580. doi:10.1001/jamasurg.2024.3260
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。